Learn which Xstrahl system is best for you based on your practice's needs. See a detailed comparison of our radiotherapy systems at https://xstrahl.com/medical-system-comparison-chart/ https://vimeo.com/711330808
Radiation therapy has a plethora of treatment uses. It is helping people not just with cancer, but with musculoskeletal, inflammatory, and benign conditions. Learn why Xstrahl strives to support both the research and clinical community worldwide in the pursuit of...
It can be difficult to treat cancer of the eyelid. Treatment with surgery often leads to tissue loss. Superficial radiotherapy can be used, but typically involves a topical anesthetic and the user of an internal eye shield, which can present risks and challenges...
Advancing radiation is only possible thanks to the large network of skilled, dedicate people working to make it happen. While so much credit appropriately goes to the researchers and clinicians at the forefront, there are key people behind the scenes paving the way....
In the recent study, Radiotherapy Delivered Before CDK4/6 Inhibitors Mediates Superior Therapeutic Effects in ER+ Breast Cancer, researchers compared various forms of treatment including radiotherapy, oral palbociclib, or a combination of both. Researchers found that...
Mutations of the phosphatase and tensin homolog (PTEN) gene can affect cancer development and cause large hamartomatous skin change in sun-exposed areas. Radiotherapy has reportedly caused increased acute toxicity for this with PTEN variants, however, this case...
What makes Xstrahl unique in the world of radiation? Hear from our CEO, Adrian Treverton on how Xstrahl connects leading researchers and clinicians, and paves the way for radiation innovation with our incredible team. https://vimeo.com/716514378
Hear from Xstrahl's CEO, Adrian Treverton and Technical Service Manager, Wilfried Goetz about increasing throughput in SARRP research with a variety of mouse beds. Radiation research can be done on multiple subjects at once. https://youtu.be/Hx0oUJ8kkxU
In the study, Radiotherapy-exposed CD8+ and CD4+ Neoantigens Enhance Tumor Control, SARRP enabled researchers to verify that radiotherapy works in concert with neoantigen vaccination to improve tumor control. See more below, and the full study here.
Contact Us